<DOC>
	<DOCNO>NCT01910116</DOCNO>
	<brief_summary>GCSB-5 ( `` Shinbaro capsule '' ) , mixture 6 oriental herbs anti-inflammatory analgesic effect along excellent safety profile . This study aim investigate efficacy Shinbaro treatment hand osteoarthritis need long term treatment placebo control , double-blind randomized trial .</brief_summary>
	<brief_title>Efficacy Shinabro Hand Osteoarthritis</brief_title>
	<detailed_description>Osteoarthritis ( OA ) common musculoskeletal disease affect 30 % elderly population . It frequently involve knee , hip , spine hand . In hand , distal proximal interphalangeal first carpometacarpal joint affect , lead often significant disability limitation daily activity . The chronic progressive nature disease require life-long treatment . The mainstay treatment hand OA target pain control . Non-steroidal anti-inflammatory drug ( NSAIDs ) often use . However , frequently associate significant gastrointestinal side effect include gastritis , peptic ulcer disease , bleeding , especially long term use . Further , ameliorate pain completely , require additional medication acetaminophen opioid-based analgesic . Shibaro mixture purify oriental herb consist Ledebouriellae Radix , Achyranthis Radix , Acanthopanacis Cortex , Cibotii Rhizoma , Glycine Semen , Eucommiae Cortex . These herb use treatment diverse inflammatory condition Chines traditional medicine . All 6 herb show excellent safety profile anti-inflammatory analgesic effect study animal human . As , give excellent safety profile , anti-inflammatory analgesic effect , Shinbaro might ideal treatment OA . This study investigate efficacy safety Shinbaro treatment hand OA placebo-controlled , randomize , double-blind , multi-center trial .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Age 40 year old Osteoarthritis accord ACR 1990 criterion Mean joint visual analog pain score ( VAS ) &gt; 30mm precede 48 hour Patients participate Any prior surgery hand joint prior history Shinbaro use Intraarticular injection glucocorticosteroid hyaluronic acid precede 3 month Pregnancy active breast feeding Prior hypersensitivity reaction herbal medication AST ALT elevation &gt; 3 upper normal limit GRF ( MDRD ) &lt; 30 mg/min/1.73m2 Nephrotic syndrome , signficant kidney disease Patients seem tolerate study investigator 's discretion Patients refuse participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>hand</keyword>
	<keyword>Shinbaro</keyword>
	<keyword>GCSB-5</keyword>
</DOC>